|
⚲
|
| Keyboard |
| Voxcell BioInnovation Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002041826 |
| Sale | 2026-08-19 (2.2 M Offered, 2.2 M Sold) |
| Fund | |
| Phone | 6729748850 |
| Address | 300637 Bay Street Victoria, A1 V8T 5L2 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-09-01 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Mark Miller | Director | |
| Jessica Miller | Director | |
| Marie-Helene Raigneau | Director | |
| Thomas Neumann | Director | |
| Karolina Valente | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Genus Capital Management Inc
✚
|
A1 | |
|
British Columbia Investment Management Corp
✚
|
A1 | |
|
Pacad Investment Ltd
✚
|
A1 | |
|
McLean Budden Ltd
✚
|
A1 | |
|
Dixon Mitchell Investment Counsel Inc
✚
|
A1 | |
|
Asia Pacific Associates III Ltd
✚
|
A1 | |
|
JPMorgan Asset Management Canada Inc
✚
|
A1 | |
|
PenderFund Capital Management Ltd
✚
|
A1 | |
|
HSBC Global Asset Management Canada LTD
✚
|
A1 | |
|
North Growth Management Ltd
✚
|
A1 |